Original Paper

Spectrum and Antibiotic Resistance of Uropathogens Isolated from Hospital and Community Patients with Urinary Tract Infections in Two Large Hospitals in Kuwait
Noura Al Sweih^a, Wafaa Jamal^b, V.O. Rotimi<sup>a, b

a</sup>Department of Microbiology, Faculty of Medicine, Kuwait University, and
^bMubarak Teaching Hospital, Kuwait

Address of Corresponding Author

Med Princ Pract 2005;14:401-407 (DOI: 10.1159/000088113)

  Key Words

• Urinary tract infection
• Uropathogens
• Antibiotic resistance

  Abstract

Objectives: To determine the spectrum of microbial etiology and antibiotic resistance pattern of the uropathogens that cause urinary tract infections in 2 large teaching hospitals in Kuwait over a period of 1 year. Materials and Methods: The Vitek identification card system was used to identify the uropathogens. Susceptibility of the isolates against 18 antibiotics was performed by the microbroth dilution method using the Vitek automated system. In addition, gram-positive bacteria were tested in parallel by the disk diffusion technique. Results: The six overall most common isolates were: Escherichia coli, accounting for 47% of isolates in both hospitals, followed by Candida spp. (10.8%), Klebsiella pneumoniae (9.6%), Streptococcus agalactiae (GBS; 9.5%), Enterococcusfaecalis (4.2%) and Pseudomonas aeruginosa (4.1%). Amikacin provided the widest coverage amongst all the antibiotics tested followed by ciprofloxacin, gentamicin and piperacillin-tazobactam. For the gram-negatives, high resistance (26-63%) to the -lactam antibiotics was noted, especially to ampicillin, amoxicillin-clavulanic acid, cephalothin and cefuroxime. Resistance to trimethoprim-sulfamethoxazole was also high. None of the enterococci was resistant to the glycopeptides, but 38-60% of the Staphylococcus haemolyticus were resistant to vancomycin or teicoplanin. Conclusion: These data show the high level of antimicrobial resistance amongst the uropathogens causing urinary tract infection in the two hospitals studied.

Copyright © 2005 S. Karger AG, Basel

  References

1.

Gastmeier P, Kampf G, Weschnewski N, Hauer T, Schulgen G, Schumacher M, Daschner F, Ruden H: Prevalence of nosocomial infections in representative German hospitals. J Hosp Infect 1998;38:37-49.

2.

Foxman B: Recurring urinary tract infection: incidence and risk factors. Am J Public Health 1990;80:331-333.

3.

Mobley HL: Virulence of the two primary uropathogens. ASM News 2000;66:403-410.

4.

Magee JT, Pritchard EL, Fitzgerald KA, Dunstan FDJ, Howard AJ: Antibiotic prescribing and antibiotic resistance in community practice: retrospective study, 1996-1998. BMJ1999;319:1239-1240.

5.

Vorland LH, Carlson K, Aalen O: An epidemiological survey of urinary tract infections among outpatients in Northern Norway. Scand J Infect Dis 1985;17:277-283.

6.

Gupta K, Hooton TM, Wobbe CL, Stamm WE: The prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in young women. Int J Antimicrob Agents1999;11:305-308.

7.

Barrett SP, Savage MA, Rebec MP, Guyot A, Andrews N, Shrimpton SM: Antibiotic sensitivity of bacteria associated with community-acquired urinary tract infections in Britain. J Antimicrob Chemother 1999;44:359-365.

8.

Jones RN, Kugler KC, Pfaller MA, Winokur PL, SENTRY Surveillance Group: Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997. Diagn Microbiol Infect Dis 1999;35:55-63.

9.

Vromen M, van der Ven AJ, Knols A, Stobberingh EE: Antimicrobial resistance patterns in urinary tract isolates from nursing home residents. Fifteen years of data reviewed. J Antimicrob Chemother 1999;44:113-116.

10.

Zhanel GG, Karlowsky JA, Harding GKM, Carrier A, Mazzulli T, Low DE, Hoban DJ: A Canadian National surveillance study of urinary tract isolates from outpatients: comparison of activities of trimethoprim-sulfamethoxazole, ampicillin, mecillinam, nitrofurantoin and ciprofloxacin. The Canadian Urinary Isolate Study Group. Antimicrob Agents Chemother 2000;44:1089-1092.

11.

Helin I, Araj GF: Antibiogram of urinary isolates in Kuwait. Scand J Infect Dis 1986;18:447-450.

12.

Russo TA, Stapleton A, Wenderoth S, Hooton TM, Stamm WE: Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women. J infect Dis 1995;172:440-445.

13.

National Committee on Clinical Laboratory Standards Performance Standards for Antimicrobial Susceptibility Testing: 12th supplement; M100-S12; 2002;22:90-95.

14.

Hryniewicz K, Szczypa K, Sulikowska A, Jankowski K, Betlejewska K, Hryniewicz W: Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland. J Antimicrob Chemother 2001;47:773-780.

15.

Navaneeth BV, Belwadi S, Sughanthi N: Urinary pathogens' resistance to common antibiotics: a retrospective analysis. Trop Doct 2002;32:20-22.

16.

Mathai D, Jones RN, Pfaller MA: SENTRY Participant Group of North America Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance program (North America). Diag Microbiol Infect Dis 2001;40:129-136.

17.

Bonadio M, Meini M, Spetaleri P, Gilgi C: Current microbiological and clinical aspects of urinary tract infections. Eur J Urol 2001;40:439-445.

18.

Grude N, Tveten Y, Kristiansen B-E: Urinary tract infections in Norway: bacterial aetiology and susceptibility. A retrospective study of clinical isolates. Clin Microbiol Infect 2001;7:543-547.

19.

Farrell DJ, Morrissey I, De Robeis D, Robbins M, Felmingham D: A UK muticentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect 2003;46:94-100.

20.

Gruneberg RN: Changes in urinary pathogens and their antibiotic sensitivities 1971-1992. J Antimicrob Chemother 1994;33(suppl A):1-8.

21.

ESCMID Study Group Report: A European perspective on nosocomial urinary tract infections. I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). Clin Microbiol Infect 2001;7:523-531.

22.

Nicolle LE, Hoban SA, Harding GK: Characterization of coagulase-negative staphylococci from urinary tract specimens. J Clin Microbiol 1983;17:267-271.

23.

Dobardzic AM, Dobardzic R: Epidemiological features of complicated UTI in a district hospital of Kuwait. Eur J Epidemiol 1997;13:465-470.

24.

Al-Sweih N, Maiyegun S, Diejomaoh M, Rotimi V, Khodakhast F, Hassan N, George S, Baig S: Streptococcus agalactiae (group B streptococci) carriage in late pregnancy in Kuwait. Med Principles Pract 2004;13:10-14.

25.

Winstanley TG, Limb DI, Eggington R, Hancock F: A 10-year survey of the antimicrobial susceptibility of urinary isolates in the UK: the Microbe Base Project. J Antimicrob Chemother 1997;40:591-594.

26.

Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE: Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDAS). Clin Infect Dis 1999;29:745-758.

  Author Contacts

Dr. Noura Al Sweih
Department of Microbiology
Faculty of Medicine, Kuwait University
PO Box 24923, Safat 13110 (Kuwait)
Tel. +965 5312300, ext. 6062, Fax +965 5332719, E-Mail nalsweih@hsc.edu.kw

  Article Information

Received: September 26, 2004
Revised: February 8, 2005
Published online: July 09, 2008
Number of Print Pages : 7
Number of Figures : 0, Number of Tables : 4, Number of References : 26

  Publication Details

Medical Principles and Practice (International Journal of the Kuwait University Health Sciences Centre)

Vol. 14, No. 6, Year 2005 (Cover Date: November-December 2005)

Journal Editor: Al Awadi, F. (Kuwait)
ISSN: 1011-7571 (Print), eISSN: 1423-0151 (Online)

For additional information: http://www.karger.com/mpp

  Drug Dosage / Copyright

Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.